Genetic Association of Glucocorticoid Receptor Gene Polymorphisms With Binge Eating
Genetic Association of Glucocorticoid Receptor Gene Polymorphisms With Binge Eating Disorders in Type 2 Diabetic Obese Female Adolescents
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan
- Zainab Khan
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Unmarried females diagnosed with Type 2 diabetes > 12 months
- Age 10-19 years
- Obesity class I and II (based on BMI range of 30 - 40).
Exclusion Criteria:
- Presence of psychosis, major psychiatric or neurocognitive disorder
- Substance use
- Untreated attention-deficit hyperactivity disorder
- Use of psychopharmacological medications or psychotherapy
- Class III obesity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SCREENING
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Group BED
Those who are diagnosed with having Binge Eating disorder.
These individuals qualified after the questionnaire was administered.
|
BED Questionnaire
|
|
NO_INTERVENTION: Group Non-BED
Those who are not diagnosed with having Binge Eating disorder
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BED
Time Frame: Baseline
|
Presence of BED detected by individuals who score high on the BEDS7 Questionnaire administered
|
Baseline
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NR3C1 Presence of variants of the GR gene (rs56149945; rs41423247)
Time Frame: Six months into the study after identifying all individuals who scored high on the BEDS7 Questionnaire
|
Presence of variants of the GR gene (rs56149945; rs41423247)
|
Six months into the study after identifying all individuals who scored high on the BEDS7 Questionnaire
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- BEDCAI37628
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.